The Readout Loud
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.Podcasts
283: A CRISPR milestone, algorithms amok, & biotech mixology
Published: Nov. 16, 2023, 8:27 p.m.Duration: 30 minutes 41 seconds
Listed in: Business
From Tradeoffs: Can the U.S. put an end to surprise ambulance bills?
Published: Nov. 13, 2023, 5:39 p.m.Duration: 29 minutes 50 seconds
Listed in: Business
282: Lillys obesity drug, the power of radiation, & a biotech implosion
Published: Nov. 9, 2023, 7:18 p.m.Duration: 37 minutes 1 second
Listed in: Business
281: Decoding biotech hype, the Sarepta saga, & au revoir to a CEO
Published: Nov. 2, 2023, 4:54 p.m.Duration: 32 minutes 29 seconds
Listed in: Business
280: ESMO highlights, Roivant's big deal, & biotech VC on the rise
Published: Oct. 26, 2023, 5:18 p.m.Duration: 29 minutes 48 seconds
Listed in: Business
279: Live from the 2023 STAT Summit
Published: Oct. 19, 2023, 3:31 p.m.Duration: 33 minutes 14 seconds
Listed in: Business
278: Merger Mondays, Ozempic panic, & CRISPR'd pigs
Published: Oct. 12, 2023, 7:33 p.m.Duration: 32 minutes 57 seconds
Listed in: Business
277: Is the Nobel committee evolving? Plus, preventing public health's wiliest virus
Published: Oct. 5, 2023, 6:18 p.m.Duration: 31 minutes 6 seconds
Listed in: Business
276: Who discovered GLP-1? Plus: BrainStorm at the FDA and biotech's slump
Published: Sept. 28, 2023, 7:51 p.m.Duration: 34 minutes 47 seconds
Listed in: Business
275: A thorny ALS debate at the FDA, and the promise of artificial wombs
Published: Sept. 21, 2023, 6:38 p.m.Duration: 33 minutes 3 seconds
Listed in: Business
274: Covids latest surge, Alnylam at the FDA, & the end of an era
Published: Sept. 14, 2023, 8:30 p.m.Duration: 39 minutes 27 seconds
Listed in: Business
273: Back to school for biotech, Biogen's potential pivot, & Illumina's next chapter
Published: Sept. 7, 2023, 8:23 p.m.Duration: 33 minutes 31 seconds
Listed in: Business
272: Vivek's star turn, leaky drug data, & biotech as family business
Published: Aug. 24, 2023, 7:41 p.m.Duration: 29 minutes 30 seconds
Listed in: Business
271: Racing for gene therapy, a pioneering approval, & startups in the lurch
Published: Aug. 18, 2023, 1 a.m.Duration: 34 minutes 56 seconds
Listed in: Business
270: Your guide to Wegovys blockbuster heart study
Published: Aug. 10, 2023, 6:25 p.m.Duration: 32 minutes 52 seconds
Listed in: Business
269: Biotech layoffs, eye drug drama, & gene therapy milestones
Published: Aug. 3, 2023, 6:43 p.m.Duration: 37 minutes 27 seconds
Listed in: Business
268: Biogen's sticky situation, Wegovy's risks, & biotech insider trading
Published: July 27, 2023, 5:35 p.m.Duration: 36 minutes 25 seconds
Listed in: Business
267: BridgeBio's big week, Lilly's Alzheimer's data, & succession at Stanford
Published: July 20, 2023, 7:04 p.m.Duration: 35 minutes 26 seconds
Listed in: Business
266: Wegovy in the brain, pivotal Alzheimer's data, & pulling Threads
Published: July 13, 2023, 6:48 p.m.Duration: 32 minutes 42 seconds
Listed in: Business
265: Novavax's CEO promises a turnaround & how Lilly roiled the obesity market
Published: June 29, 2023, 6:12 p.m.Duration: 35 minutes 1 second
Listed in: Business
264: Messy PBM conflicts, debatable vaccines, & the future of flu season
Published: June 22, 2023, 7:30 p.m.Duration: 36 minutes 35 seconds
Listed in: Business
263: Biogen's messy board, Laronde's data problem, & the downside of a boom
Published: June 15, 2023, 8:05 p.m.Duration: 39 minutes 57 seconds
Listed in: Business
262: Merck v. USA, the best of ASCO, and Leqembi at the FDA
Published: June 8, 2023, 8:03 p.m.Duration: 29 minutes 52 seconds
Listed in: Business
261: Fake medical devices, real cancer drugs, & curious Ozempic effects
Published: June 1, 2023, 8:16 p.m.Duration: 31 minutes 28 seconds
Listed in: Business
260: ChatGPT in medicine, a boom in weight loss pills, & Sarepta at the FDA
Published: May 25, 2023, 7:06 p.m.Duration: 31 minutes 18 seconds
Listed in: Business
259: The FTC v. Amgen, Sarepta's future, & Galapagos' turnaround
Published: May 18, 2023, 7:10 p.m.Duration: 40 minutes 21 seconds
Listed in: Business
258: Pharma vs. PBMs, Sarepta at the FDA, & a bold idea gone awry
Published: May 11, 2023, 6:22 p.m.Duration: 31 minutes 47 seconds
Listed in: Business
257: Lilly's Alzheimer's success, a milestone FDA approval, & Moderna's shrinking business
Published: May 4, 2023, 7:59 p.m.Duration: 34 minutes 58 seconds
Listed in: Business
256: Explaining the E.U.'s pharma overhaul, Lilly's booming business, & a long-awaited drug approval
Published: April 27, 2023, 6:05 p.m.Duration: 28 minutes 58 seconds
Listed in: Business
255: Sarepta's pivotal moment, biotech's big week, & the future of Covid boosters
Published: April 20, 2023, 6:17 p.m.Duration: 39 minutes 7 seconds
Listed in: Business
254: The legal battle over abortion, an FDA 'bully pulpit' and Moderna's future
Published: April 13, 2023, 6:30 p.m.Duration: 40 minutes 1 second
Listed in: Business
253: Illuminas boardroom intrigue, the next big Alzheimers readout, & J&Js creative lawyers
Published: April 6, 2023, 4:16 p.m.Duration: 36 minutes 8 seconds
Listed in: Business
252: Biotech's monkey shortage, the broken generics market, & conference cancel culture
Published: March 30, 2023, 5:44 p.m.Duration: 36 minutes
Listed in: Business
251: Bancel v. Bernie, Sarepta's FDA runaround, & Regeneron's ever-growing blockbuster
Published: March 23, 2023, 5:27 p.m.Duration: 34 minutes 22 seconds
Listed in: Business
250: SVB's long biotech shadow, pushy AI algorithms, & Icahn v. Illumina
Published: March 16, 2023, 7:22 p.m.Duration: 35 minutes 48 seconds
Listed in: Business
249: Robert Califf on how drugs get approved, plus the nascent revolution in obesity
Published: March 9, 2023, 8:27 p.m.Duration: 38 minutes
Listed in: Business
248: The next CRISPR fight, cheaper insulin, & an FDA shuffle
Published: March 2, 2023, 6:59 p.m.Duration: 28 minutes 36 seconds
Listed in: Business
247: Vertex vs. insurers, Moderna's future, & biotech's long winter
Published: Feb. 23, 2023, 6:22 p.m.Duration: 38 minutes 7 seconds
Listed in: Business
246: Vas Narasimhan on the future of pharma, plus Modernas promise & a biotech presidential bid
Published: Feb. 16, 2023, 7:02 p.m.Duration: 40 minutes 4 seconds
Listed in: Business
245: The return of bird flu and the effects of pandemic fatigue
Published: Feb. 9, 2023, 7:32 p.m.Duration: 20 minutes 53 seconds
Listed in: Business
244: Pharma blockbusters, pandemic policy, & legal chicanery
Published: Feb. 2, 2023, 7:22 p.m.Duration: 35 minutes 29 seconds
Listed in: Business
243: George Scangos' retirement, annual Covid vaccines, an Alzheimer's drug rejection
Published: Jan. 26, 2023, 7:28 p.m.Duration: 31 minutes 35 seconds
Listed in: Business
242: How blockbusters get made, new vaccines for RSV, and mRNA's Q score
Published: Jan. 19, 2023, 7:07 p.m.Duration: 32 minutes 27 seconds
Listed in: Business
241: #JPM23 in review, the year ahead, & the merits of Miami
Published: Jan. 12, 2023, 5:24 p.m.Duration: 32 minutes 46 seconds
Listed in: Business
240: #JPM23, the future of Alzheimer's, & rising Covid variants
Published: Jan. 5, 2023, 6:50 p.m.Duration: 36 minutes 5 seconds
Listed in: Business
239: 2022 in review, CEO indictments, & the year ahead
Published: Dec. 22, 2022, 7:55 p.m.Duration: 29 minutes 27 seconds
Listed in: Business
238: Leaky health data, ASH22, & what it takes to get booed by your peers
Published: Dec. 15, 2022, 7:55 p.m.Duration: 36 minutes 21 seconds
Listed in: Business
237: The 'electric vehicles' of pharma, Illumina's boondoggle, & a Theranos sentencing
Published: Dec. 8, 2022, 7:03 p.m.Duration: 35 minutes 41 seconds
Listed in: Business
236: Wither PhRMA, Alzheimer's treatment data revealed, and the first fecal microbiome drug approval
Published: Dec. 1, 2022, 9:26 p.m.Duration: 33 minutes 25 seconds
Listed in: Business
235: LIVE from the STAT Summit
Published: Nov. 17, 2022, 6:53 p.m.Duration: 28 minutes 52 seconds
Listed in: Business
234: Biogen's new CEO, how the midterms affect science, & a biotech bankruptcy
Published: Nov. 10, 2022, 6:59 p.m.Duration: 32 minutes 56 seconds
Listed in: Business
233: How the biotech revolution could come apart at the seams
Published: Nov. 3, 2022, 5:55 p.m.Duration: 29 minutes 40 seconds
Listed in: Business
232: Anti-science at the polls, a biotech odd couple, & the stakes of the midterms
Published: Oct. 27, 2022, 5:48 p.m.Duration: 23 minutes 27 seconds
Listed in: Business
231: BU's Covid tinkering, FDA on trial, & why it's hard to take drugs off the market
Published: Oct. 20, 2022, 7:01 p.m.Duration: 34 minutes 32 seconds
Listed in: Business
230: BIO's messy transition, mRNA's future, & Biogen's next CEO
Published: Oct. 13, 2022, 6:55 p.m.Duration: 33 minutes 42 seconds
Listed in: Business
229: Nobels for science, biotech dealmaking, & a friendly FTC
Published: Oct. 6, 2022, 5:41 p.m.Duration: 28 minutes
Listed in: Business
228: A surprise success in Alzheimer's and how FDA history seeded modern controversy
Published: Sept. 29, 2022, 7:37 p.m.Duration: 35 minutes 40 seconds
Listed in: Business
227: Biden's Covid declaration, twilight of the SPAC, & genome editing 2.0
Published: Sept. 22, 2022, 8:12 p.m.Duration: 34 minutes 26 seconds
Listed in: Business
226: Pharma's telehealth gold mine, the return of the biotech IPO, & a merger deferred
Published: Sept. 15, 2022, 7:13 p.m.Duration: 27 minutes 52 seconds
Listed in: Business
225: Illumina's $8 billion limbo, a new treatment for ALS, & Emirati biotech funding
Published: Sept. 8, 2022, 8:02 p.m.Duration: 33 minutes 19 seconds
Listed in: Business
224: The anti-aging research boom, the Godfather of biotech, & the future of Biogen
Published: Sept. 1, 2022, 5 p.m.Duration: 34 minutes 34 seconds
Listed in: Business
223: Fauci's non-retirement, grading biotech VCs, & a bellwether IPO
Published: Aug. 25, 2022, 7:19 p.m.Duration: 30 minutes 9 seconds
Listed in: Business
222: Private equity in autism care, a watershed FDA approval, & the future of ALS treatment
Published: Aug. 18, 2022, 6 p.m.Duration: 29 minutes
Listed in: Business
221: Big egos in Big Science, the return of Merger Monday, & the fallout over drug pricing
Published: Aug. 11, 2022, 7:01 p.m.Duration: 29 minutes 56 seconds
Listed in: Business
220: The last-minute push for drug pricing reform, Alnylam's success, and Sarepta's gamble
Published: Aug. 4, 2022, 7:46 p.m.Duration: 33 minutes 1 second
Listed in: Business
219: Helen Branswell on monkeypox, plus: an FDA controversy and fake Alzheimer's data
Published: July 28, 2022, 5:45 p.m.Duration: 35 minutes 36 seconds
Listed in: Business
218: Well-paid CEOs, behind the scenes at Moderna, & Biogen's CEO search
Published: July 21, 2022, 6:27 p.m.Duration: 38 minutes 27 seconds
Listed in: Business
217: CRISPR for the heart, biotech's recovery, & what it means to be a 'hot girl'
Published: July 14, 2022, 5:19 p.m.Duration: 30 minutes 54 seconds
Listed in: Business
216: VC malaise, FDA confusion, & yet another Alzheimer's debate
Published: July 7, 2022, 6:13 p.m.Duration: 28 minutes 42 seconds
Listed in: Business
215: Medical privacy post-Roe, fixing clinical trials, & the next Covid vaccines
Published: June 30, 2022, 7:22 p.m.Duration: 34 minutes 9 seconds
Listed in: Business
214: Juul's doomsday, Merck's buyout plans, & the next Theranos verdict
Published: June 23, 2022, 6:40 p.m.Duration: 27 minutes 23 seconds
Listed in: Business
213: How the Fed affects biotech, Paul Offit on vaccines for kids, & another Alzheimer's setback
Published: June 16, 2022, 7:53 p.m.Duration: 35 minutes 17 seconds
Listed in: Business
212: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy
Published: June 9, 2022, 7:35 p.m.Duration: 35 minutes 52 seconds
Listed in: Business
211: Biotech's catch-22, a $100 genome, & dealing with monkeypox
Published: June 2, 2022, 6:52 p.m.Duration: 33 minutes 25 seconds
Listed in: Business
210: Covid vaccines for the youngest kids, ASCO preview, & a biotech CEOs arrest on murder charges
Published: May 26, 2022, 8:03 p.m.Duration: 34 minutes 41 seconds
Listed in: Business
Episode 209: Mysterious infections, dwindling Covid funds, & Shkreli out of prison
Published: May 19, 2022, 7:32 p.m.Duration: 33 minutes 21 seconds
Listed in: Business
Episode 208: A CEO's arrest, Pfizer's big deal, & Covid on the rise
Published: May 12, 2022, 7:05 p.m.Duration: 32 minutes 4 seconds
Listed in: Business
Episode 207: Succession at Biogen, surprises at Vertex, & a potential superspreader dinner
Published: May 5, 2022, 3:19 p.m.Duration: 31 minutes 18 seconds
Listed in: Business
Episode 206: How cancer-killing cell therapies work, biotech's endless downturn, & an FDA conundrum
Published: April 28, 2022, 2:27 p.m.Duration: 29 minutes 3 seconds
Listed in: Business
Episode 205: An ominous biotech deal, vaccines for kids, & 'breakthrough' devices
Published: April 21, 2022, 8 p.m.Duration: 32 minutes 59 seconds
Listed in: Business
Episode 204: Leana Wen on the pandemic's new normal and whether Twitter is real life
Published: April 14, 2022, 6:23 p.m.Duration: 38 minutes 19 seconds
Listed in: Business
Episode 203: What's next for Roche, a debate over second boosters, & Vertex's recent success
Published: April 7, 2022, 7:14 p.m.Duration: 33 minutes 31 seconds
Listed in: Business
Introducing: Color Code
Published: March 31, 2022, 1:45 p.m.Duration: 29 minutes 26 seconds
Listed in: Business
Episode 202: Helen Branswell on the pandemic, plus the next FDA debate & the perks of being a CEO
Published: March 24, 2022, 6:33 p.m.Duration: 35 minutes 1 second
Listed in: Business
Episode 201: Doing biotech in Ukraine, drug pricing deja vu, & Covid surges overseas
Published: March 17, 2022, 6:57 p.m.Duration: 31 minutes 6 seconds
Listed in: Business
Episode 200: Gilead's growing pains, Covid's origins, & Theranos as prestige TV
Published: March 10, 2022, 8:21 p.m.Duration: 31 minutes 34 seconds
Listed in: Business
Episode 199: Biden's plans for Covid pills, the latest vaccine data, & fighting about CRISPR
Published: March 3, 2022, 8:31 p.m.Duration: 30 minutes 12 seconds
Listed in: Business
Episode 198: Medical racism, new Covid vaccines, & the resilience of Regeneron
Published: Feb. 24, 2022, 6:56 p.m.Duration: 30 minutes 39 seconds
Listed in: Business
Episode 197: Robert Califf's FDA return, the future of CRISPR, & another vaccine delay
Published: Feb. 17, 2022, 7:03 p.m.Duration: 35 minutes 8 seconds
Listed in: Business
Episode 196: Eric Lander's resignation, FDA's about-face, & Pfizer's lucrative pandemic
Published: Feb. 10, 2022, 7:24 p.m.Duration: 34 minutes 40 seconds
Listed in: Business
Episode 195: Califf's sudden jeopardy, the quest for a PCSK9 pill, & Covid vaccines for kids
Published: Feb. 3, 2022, 8:48 p.m.Duration: 33 minutes 39 seconds
Listed in: Business
Episode 194: Janet Woodcock on Covid antibodies, vaccines for kids, and responding to Omicron
Published: Jan. 27, 2022, 6:34 p.m.Duration: 25 minutes 25 seconds
Listed in: Business
Episode 193: Jared Holz on Biotech's red tape, plus the latest billionaire science project
Published: Jan. 20, 2022, 7:51 p.m.Duration: 33 minutes 50 seconds
Listed in: Business
Episode 192: Michael Gilman on the future of RNA drugs, plus #JPM22 in review and more Biogen news
Published: Jan. 13, 2022, 7:45 p.m.Duration: 34 minutes 47 seconds
Listed in: Business
Episode 191: Craig Spencer on the Omicron surge + biotech in 2022, & the Elizabeth Holmes verdict
Published: Jan. 6, 2022, 9:14 p.m.Duration: 31 minutes 1 second
Listed in: Business
Episode 190: Covid in 2022, J.P. Morgan bows to pressure, & the year in review
Published: Dec. 16, 2021, 8:39 p.m.Duration: 35 minutes 20 seconds
Listed in: Business
Episode 189: Biogen, Biogen, Biogen, with a dash of Omicron
Published: Dec. 9, 2021, 8:55 p.m.Duration: 29 minutes 55 seconds
Listed in: Business
Episode 188: Carlos del Rio on Covid antivirals, an FDA conundrum, & the rise of Omicron
Published: Dec. 2, 2021, 7:32 p.m.Duration: 32 minutes 12 seconds
Listed in: Business
Episode 187: Biogens scientific succession & Michael Osterholm on pandemic Thanksgiving
Published: Nov. 18, 2021, 9:01 p.m.Duration: 35 minutes 19 seconds
Listed in: Business
Episode 186: Rebecca Robbins on Moderna v. NIH, plus psilocybin as a medicine
Published: Nov. 11, 2021, 8:01 p.m.Duration: 30 minutes 9 seconds
Listed in: Business
Episode 185: John Maraganore on his next act, plus Moderna's setback & the drug pricing reform saga
Published: Nov. 4, 2021, 7:59 p.m.Duration: 28 minutes 22 seconds
Listed in: Business
Episode 184: Vaccines for kids, inside Operation Warp Speed, & a big biotech resignation
Published: Oct. 28, 2021, 7:56 p.m.Duration: 33 minutes 29 seconds
Listed in: Business
Episode 183: Greg Zuckerman on the vaccine race, plus Biogen's troubled launch
Published: Oct. 21, 2021, 6:57 p.m.Duration: 30 minutes 50 seconds
Listed in: Business
Episode 182: The FDA star search, more booster debates, & the future of mRNA
Published: Oct. 14, 2021, 8:14 p.m.Duration: 33 minutes 25 seconds
Listed in: Business
Episode 181: Brent Hodge on filming Shkreli, the next NIH director, and a looming FDA deadline
Published: Oct. 7, 2021, 7:43 p.m.Duration: 33 minutes 26 seconds
Listed in: Business
Episode 180: Health equity 'tourism,' an $11B biopharma acquisition, & a bony Covid protest
Published: Sept. 30, 2021, 7:52 p.m.Duration: 28 minutes 40 seconds
Listed in: Business
Episode 179: Scott Gottlieb on the next pandemic, another Covid winter, & Aduhelm's slow rollout
Published: Sept. 23, 2021, 7:35 p.m.Duration: 36 minutes 35 seconds
Listed in: Business
Episode 178: Futuristic prosthetics, a treatment for ALS, & intrigue at the Holmes trial
Published: Sept. 16, 2021, 7:41 p.m.Duration: 35 minutes 9 seconds
Listed in: Business
Episode 177: Bijan Salehizadeh on Covid tests, plus Verily's moment of truth
Published: Sept. 9, 2021, 7:38 p.m.Duration: 36 minutes 29 seconds
Listed in: Business
Episode 176: Elizabeth Holmes on trial, FDA in disarray, & the quest for Covid antivirals
Published: Sept. 2, 2021, 7 p.m.Duration: 33 minutes 54 seconds
Listed in: Business
Episode 175: Dorit Reiss on vaccine mandates, plus biotech's messy summer
Published: Aug. 26, 2021, 8:16 p.m.Duration: 29 minutes 39 seconds
Listed in: Business
Episode 174: Biotech's trust issues, overwhelmed health workers, & the nuances of insider trading
Published: Aug. 19, 2021, 6:39 p.m.Duration: 28 minutes 15 seconds
Listed in: Business
Episode 173: Biden's drug pricing plan, Wall Street's Alzheimer's fixation, & daily 5 a.m. alarms
Published: Aug. 12, 2021, 8:10 p.m.Duration: 30 minutes 51 seconds
Listed in: Business
Episode 172: The mRNA gold rush, Delta's alarming rise, & the next treatment for Alzheimer's
Published: Aug. 5, 2021, 7:16 p.m.Duration: 33 minutes 4 seconds
Listed in: Business
Episode 171: The quest for a Covid pill, a microbiome gut-check, & CRISPR on the big screen
Published: July 29, 2021, 6:41 p.m.Duration: 34 minutes 52 seconds
Listed in: Business
Episode 170: Celine Gounder on breakthrough infections, plus the power of lobbying
Published: July 22, 2021, 7:54 p.m.Duration: 32 minutes 36 seconds
Listed in: Business
Episode 169: Dan Diamond on covering Biden, plus the FDA's future, & the latest Aduhelm twist
Published: July 15, 2021, 8:31 p.m.Duration: 30 minutes 24 seconds
Listed in: Business
Episode 168: Aduhelm's latest twist, & how Covid variants are shaping the summer
Published: July 8, 2021, 7:46 p.m.Duration: 31 minutes 5 seconds
Listed in: Business
Episode 167: George Yancopoulos on biotech in 2021, plus a CRISPR milestone, Biogen's FDA saga,
Published: July 1, 2021, 8:32 p.m.Duration: 43 minutes 21 seconds
Listed in: Business
Episode 166: FDA inner workings, GSK's foggy future, & the alarming rise in colorectal cancer
Published: June 24, 2021, 7:50 p.m.Duration: 37 minutes 55 seconds
Listed in: Business
Episode 165: Paul Offit on the Covid vaccine booster debate, & Robyn Karnauskas' call of the decade
Published: June 17, 2021, 7:46 p.m.Duration: 34 minutes 30 seconds
Listed in: Business
Episode 164: Every angle on the FDA's polarizing approval of Biogen's Alzheimer's drug
Published: June 10, 2021, 8:33 p.m.Duration: 40 minutes 48 seconds
Listed in: Business
Episode 163: Marilynn Marchione on covering the CRISPR babies scandal
Published: June 3, 2021, 7:51 p.m.Duration: 28 minutes 12 seconds
Listed in: Business
Episode 162: Scott Gottlieb on Covid and grilling, plus how Zolgensma has changed SMA
Published: May 27, 2021, 8:41 p.m.Duration: 32 minutes 35 seconds
Listed in: Business
Episode 161: Biotech meme stocks, the lessons of Spanish Flu, & becoming a pandemic celebrity
Published: May 20, 2021, 8:58 p.m.Duration: 38 minutes 9 seconds
Listed in: Business
Episode 160: Global Covid-19 failures, a sluggish CDC, and a boisterous STAT Health Tech Summit
Published: May 13, 2021, 8:17 p.m.Duration: 29 minutes 19 seconds
Listed in: Business
Episode 159: Thomas Bollyky on patent waivers, plus vaccine riches, & a gene therapy for aging
Published: May 6, 2021, 9:34 p.m.Duration: 33 minutes 16 seconds
Listed in: Business
Episode 158: Angela Rasmussen on Russia's vaccine controversy, plus Biden's drug pricing punt
Published: April 29, 2021, 8:45 p.m.Duration: 28 minutes 4 seconds
Listed in: Business
Episode 157: Mercedes Carnethon on outdoor masking, FDA in limbo, & gene therapy's uncertain upside
Published: April 22, 2021, 7:59 p.m.Duration: 33 minutes 9 seconds
Listed in: Business
Episode 156: J&J's vaccine pause, talking about remote risks, & why no new drugs for Covid-19
Published: April 15, 2021, 7:46 p.m.Duration: 30 minutes 37 seconds
Listed in: Business
Episode 155: AstraZeneca's vaccine woes, compassionate use, & giving out Covid vaccines
Published: April 8, 2021, 7:51 p.m.Duration: 30 minutes 26 seconds
Listed in: Business
Episode 154: Eleanor Fox on Illuminas FTC headache, plus Talkspaces experiment
Published: April 1, 2021, 8:54 p.m.Duration: 33 minutes 5 seconds
Listed in: Business
Episode 153: AstraZeneca and the very good, then quite bad, then deeply confusing week
Published: March 25, 2021, 8:06 p.m.Duration: 27 minutes 14 seconds
Listed in: Business
Episode 152: Alison Buttenheim on Europe's vaccine scare, Lilly's Alzheimer's data, & a PR plea
Published: March 18, 2021, 7:53 p.m.Duration: 29 minutes 38 seconds
Listed in: Business
Episode 151: Natasha Loder on Covid vaccines, the demise of Watson Health, and a 'synbio' explainer
Published: March 11, 2021, 8:31 p.m.Duration: 29 minutes 2 seconds
Listed in: Business
Episode 150: Ashish Jha on Covid-19 optimism, plus pharma cooperation, & the next pandemic phase
Published: March 4, 2021, 10:37 p.m.Duration: 31 minutes 51 seconds
Listed in: Business
Episode 149: Nancy Goodman on Covid vaccines for kids, & Greg Zuckerman on Novavax's remarkable rise
Published: Feb. 25, 2021, 9:45 p.m.Duration: 31 minutes 58 seconds
Listed in: Business
Episode 148: Akshay Sharma on gene therapy's setback, biotech's brashest VCs, & the FDA's future
Published: Feb. 18, 2021, 9:58 p.m.Duration: 35 minutes 42 seconds
Listed in: Business
Episode 147: David Fajgenbaum on Covid-19 drugs, the state of the pandemic, & meme biotech stocks
Published: Feb. 11, 2021, 9:28 p.m.Duration: 35 minutes 27 seconds
Listed in: Business
Episode 146: Paul Offit on vaccine data, 23andMe is going public, & Merck's CEO is retiring
Published: Feb. 4, 2021, 9:27 p.m.Duration: 34 minutes 16 seconds
Listed in: Business
Episode 145: Kevin Davies on the CRISPR boom, & Megan Ranney on scientific misinformation
Published: Jan. 28, 2021, 9:54 p.m.Duration: 34 minutes 16 seconds
Listed in: Business
Episode 144: Remembering STAT's Sharon Begley
Published: Jan. 22, 2021, 1:10 a.m.Duration: 39 minutes 40 seconds
Listed in: Business
Episode 143: #JPM21: Deja vu in Alzheimer's research, and OWS's legacy
Published: Jan. 14, 2021, 9:34 p.m.Duration: 29 minutes 59 seconds
Listed in: Business
Episode 142: Bob Nelsen on the pandemic's next phase, plus Biden's biopharma plans & a CES preview
Published: Jan. 7, 2021, 10:08 p.m.Duration: 29 minutes 14 seconds
Listed in: Business
Episode 141: Moderna's vaccine milestone, Warp Speed's hurdles, and biotech in 2021
Published: Dec. 18, 2020, 4:56 p.m.Duration: 34 minutes 55 seconds
Listed in: Business
Episode 140: Pfizer's Covid-19 vaccine the debate, details, and distribution
Published: Dec. 11, 2020, 7:42 p.m.Duration: 33 minutes 50 seconds
Listed in: Business
Episode 139: Angela Rasmussen on AstraZeneca's confusing data, & Adam Koppel on biotech in 2021
Published: Dec. 3, 2020, 9:34 p.m.Duration: 28 minutes 38 seconds
Listed in: Business
Episode 138: The latest Covid-19 vaccine, Biden's pandemic plans, and Bill Gates unfiltered
Published: Nov. 19, 2020, 9:54 p.m.Duration: 23 minutes 7 seconds
Listed in: Business
Episode 137: Natalie Dean on Pfizer's Covid-19 vaccine, plus the FDA's Alzheimer's quandary
Published: Nov. 12, 2020, 10:34 p.m.Duration: 29 minutes 23 seconds
Listed in: Business
Bracing for a pandemic winter, Biogen's fortune at the FDA, and remembering a remarkable 12-year-old
Published: Nov. 5, 2020, 10:51 p.m.Duration: 26 minutes 42 seconds
Listed in: Business
Episode 135: Pfizer's Covid-19 mystery, Ashish Jha on pandemic response, & STAT turns 5
Published: Oct. 29, 2020, 9:22 p.m.Duration: 29 minutes 52 seconds
Listed in: Business
Episode 134: Erik Gordon on SPACs, plus Covid-19 vaccines, & Biogen's case in Alzheimer's
Published: Oct. 22, 2020, 8:31 p.m.Duration: 24 minutes 59 seconds
Listed in: Business
Episode 133: A week of pauses, pharmas statehouse spending, & how HBCUs approach Covid-19 trials
Published: Oct. 15, 2020, 9:56 p.m.Duration: 28 minutes 6 seconds
Listed in: Business
Episode 132: How Trump's case of Covid-19 affects biotech, medicine, and the FDA with George Scangos
Published: Oct. 8, 2020, 9:03 p.m.Duration: 23 minutes 7 seconds
Listed in: Business
Episode 131: Saad Omer on Covid-19 vaccine trials, & Ethan Weiss on intermittent fasting
Published: Oct. 1, 2020, 8:31 p.m.Duration: 25 minutes 6 seconds
Listed in: Business
Episode 130: A road map for Covid-19, the gold rush in health tech, & D.C.'s pandemic unrest
Published: Sept. 24, 2020, 8:38 p.m.Duration: 25 minutes 46 seconds
Listed in: Business
Episode 129: Heidi Tworek on pandemic PR, plus the CDC's credibility crisis & a lightning round
Published: Sept. 17, 2020, 7:34 p.m.Duration: 26 minutes 25 seconds
Listed in: Business
Episode 128: AstraZenecas Covid-19 vaccine, coronavirus politics, & STATs Health Tech Summit
Published: Sept. 10, 2020, 8:33 p.m.Duration: 25 minutes 3 seconds
Listed in: Business
Episode 127: Eric Topol on Stephen Hahn, plus Covid-19 vaccine timelines, & the 2000th First Opinion
Published: Sept. 3, 2020, 7:22 p.m.Duration: 24 minutes 31 seconds
Listed in: Business
Episode 126: The FDA's chaotic week, Trump's effect on science, and Musk's big reveal
Published: Aug. 27, 2020, 8:52 p.m.Duration: 24 minutes 38 seconds
Listed in: Business
Episode 125: Shocking FDA rejections, a longevity science setback & Derek Lowe on Covid-19 vaccines
Published: Aug. 20, 2020, 8:54 p.m.Duration: 19 minutes 25 seconds
Listed in: Business
Episode 124: Pharma's lobbying dollars, Alnylam's future, and diversity in Covid-19 studies
Published: Aug. 13, 2020, 8:01 p.m.Duration: 26 minutes 48 seconds
Listed in: Business
Episode 123: Steven Salzberg's Twitter debate, a health tech mega-deal & Covid-19 vaccine prices
Published: Aug. 6, 2020, 8:07 p.m.Duration: 24 minutes 49 seconds
Listed in: Business
Episode 122: Gary Washburn on the NBA bubble, plus a DIY coronavirus vaccine, & behind VC numbers
Published: July 30, 2020, 6:51 p.m.Duration: 25 minutes 36 seconds
Listed in: Business
Episode 121: Kate Bingham on vaccine data, Meg Tirrell on covering Covid-19, & a DNA detective story
Published: July 23, 2020, 8:46 p.m.Duration: 25 minutes 15 seconds
Listed in: Business
Episode 120: Moderna's vaccine data, saving the U.S. pandemic response & systemic racism in medicine
Published: July 16, 2020, 8:17 p.m.Duration: 25 minutes 57 seconds
Listed in: Business
Episode 119: Trump's FDA pressure, a microcosm of the pandemic, and squabbling over a vaccine
Published: July 9, 2020, 7:19 p.m.Duration: 25 minutes 51 seconds
Listed in: Business
Episode 118: Remdesivirs controversial cost, early vaccine promise, and AI at the end of life
Published: July 2, 2020, 5:23 p.m.Duration: 22 minutes 25 seconds
Listed in: Business
Episode 117: Covid-19s U.S. surge, GSKs mystery whistleblower, and cancer care under coronavirus
Published: June 25, 2020, 8:52 p.m.Duration: 22 minutes 48 seconds
Listed in: Business
Episode 116: Ezekiel Emanuel on vaccine politics & Tshaka Cunningham on diversifying genetic testing
Published: June 18, 2020, 9:28 p.m.Duration: 26 minutes 25 seconds
Listed in: Business
Episode 115: The Chan-Zuck uprising, a virtual BIO, and the struggle to treat Covid-19
Published: June 11, 2020, 8:46 p.m.Duration: 21 minutes 2 seconds
Listed in: Business
Episode 114: The killing of George Floyd, the drug industry's response, and what comes next
Published: June 4, 2020, 9:03 p.m.Duration: 22 minutes 40 seconds
Listed in: Business
Episode 113: Life after a coronavirus vaccine, virtual ASCO, and remembering Larry Kramer
Published: May 28, 2020, 7:47 p.m.Duration: 26 minutes 57 seconds
Listed in: Business
Episode 112: Moderna's scant coronavirus data and the plight of the day trader
Published: May 21, 2020, 8:10 p.m.Duration: 19 minutes 24 seconds
Listed in: Business
Episode 111: Covid-19 in the White House, a Parkinsons experiment & public health lessons from porn
Published: May 14, 2020, 8:02 p.m.Duration: 26 minutes 59 seconds
Listed in: Business
Episode 110: Pandemic projections, Gilead's pricing dilemma & fighting Covid-19 in New York
Published: May 7, 2020, 8:18 p.m.Duration: 27 minutes
Listed in: Business
Episode 109: Scott Gottlieb on Covid-19 treatments, reopening America, and going on TV every day
Published: April 30, 2020, 9:25 p.m.Duration: 25 minutes 23 seconds
Listed in: Business
Episode 108: A vaccine official is ousted, how to use ventilators, & the fate of the JPM conference
Published: April 23, 2020, 8:51 p.m.Duration: 29 minutes 3 seconds
Listed in: Business
Episode 107: Covid-19 disrupts D.C., how not to be boring on Zoom, and the trial of Elizabeth Holmes
Published: April 16, 2020, 7:04 p.m.Duration: 26 minutes 48 seconds
Listed in: Business
Episode 106: Privacy in a pandemic, biopharma's big opportunity, and Shkreli's plea for a break
Published: April 9, 2020, 8:54 p.m.Duration: 24 minutes 55 seconds
Listed in: Business
Episode 105: Pandemic exit strategies, how the outbreak affects patients, and Ken Burns takes on DNA
Published: April 2, 2020, 8:06 p.m.Duration: 23 minutes 59 seconds
Listed in: Business
Episode 104: Fauci's star turn, the latest on coronavirus, and an under-the-radar Alzheimer's drug
Published: March 26, 2020, 7:13 p.m.Duration: 28 minutes 5 seconds
Listed in: Business
Episode 103: Trump's coronavirus pivot, life inside the ICU & drug development in a pandemic
Published: March 19, 2020, 9:05 p.m.Duration: 25 minutes 26 seconds
Listed in: Business
Episode 102: Voices from the coronavirus pandemic, in Italy, New York, and the high seas
Published: March 12, 2020, 9:45 p.m.Duration: 25 minutes 7 seconds
Listed in: Business
Episode 101: Pharmas response to coronavirus, Google's appetite for health data, & biotech in China
Published: March 5, 2020, 10:28 p.m.Duration: 28 minutes 29 seconds
Listed in: Business
Episode 100: Wall Street's coronavirus freakout, clinical trial difficulties, and a look back
Published: Feb. 27, 2020, 10:04 p.m.Duration: 28 minutes 47 seconds
Listed in: Business
Episode 99: Genetic medicine w/ Ethan Weiss, drug industry infighting, & a microbiome review
Published: Feb. 20, 2020, 9:35 p.m.Duration: 29 minutes 56 seconds
Listed in: Business
Episode 98: Les Funtleyder on biotech investing; the Zolgensma lottery & billionaire philanthropy
Published: Feb. 13, 2020, 9:38 p.m.Duration: 24 minutes 49 seconds
Listed in: Business
Episode 97: Fake outbreak news, treating coronavirus, and biotech's Mount Rushmore
Published: Feb. 6, 2020, 9:22 p.m.Duration: 23 minutes 30 seconds
Listed in: Business
Episode 96: A chemist breaks bad, the latest on the coronavirus, and pharmas slow Bern
Published: Jan. 30, 2020, 9:23 p.m.Duration: 26 minutes 19 seconds
Listed in: Business
Episode 95: The latest on the China virus, Sarepta's ongoing FDA saga, and biotech at Davos
Published: Jan. 23, 2020, 9:06 p.m.Duration: 22 minutes 2 seconds
Listed in: Business
Episode 94: EQRx's Alexis Borisy, Stephen Buck on his website for cancer patients, and a JPM recap
Published: Jan. 16, 2020, 9:33 p.m.Duration: 23 minutes 15 seconds
Listed in: Business
Episode 93: Josiah Zayner on getting canceled, good news in cancer, an Ebola vaccine saga
Published: Jan. 9, 2020, 7:49 p.m.Duration: 26 minutes 29 seconds
Listed in: Business
Episode 92: The decade in breakthroughs, the year in bad CEOs, and the viruses that cure disease
Published: Dec. 19, 2019, 9:12 p.m.Duration: 24 minutes 51 seconds
Listed in: Business
Episode 91: CAR-T's future, an alarming cancer trend & Chris Garabedian on Sarepta's FDA legacy
Published: Dec. 12, 2019, 9:10 p.m.Duration: 25 minutes 29 seconds
Listed in: Business
Episode 90: Biogen's big reveal, hot takes on Alzheimer's, & the science of one-eyed sheep
Published: Dec. 5, 2019, 10:31 p.m.Duration: 24 minutes 46 seconds
Listed in: Business
Episode 89: Warren's awkward home front, a dwarfism drug, and the sound of STAT Summit
Published: Nov. 22, 2019, 8:26 p.m.Duration: 24 minutes 56 seconds
Listed in: Business
Episode 88: Dr. David Sable on an alarming genetic test & Jorge Conde on the perils of bio-Twitter
Published: Nov. 14, 2019, 8:58 p.m.Duration: 25 minutes 58 seconds
Listed in: Business
Episode 87: Derek Lowe on China's new Alzheimer's drug, blockbuster fish oil, & STAT's birthday
Published: Nov. 7, 2019, 8:56 p.m.Duration: 20 minutes 6 seconds
Listed in: Business
Episode 86: Drugs that don't work, wearables in the desert, & excess 'innovation'
Published: Oct. 31, 2019, 9:12 p.m.Duration: 28 minutes 13 seconds
Listed in: Business
Episode 85: Every angle on Biogen's shocking Alzheimer's news
Published: Oct. 24, 2019, 9:37 p.m.Duration: 28 minutes 18 seconds
Listed in: Business
Episode 84: CRISPR with Netflix filmmakers, Pharma's future in China & where VC dollars come from
Published: Oct. 17, 2019, 8:39 p.m.Duration: 26 minutes 13 seconds
Listed in: Business
Episode 83: How biotech VC works w/ health care journalist Maggie Fox, Vioxx and synthetic biology
Published: Oct. 10, 2019, 8:37 p.m.Duration: 23 minutes 46 seconds
Listed in: Business
Episode 82: Drug shortages with Dr. Ben Davies, congressional paralysis & biotech's foul mood
Published: Oct. 3, 2019, 8:17 p.m.Duration: 23 minutes 17 seconds
Listed in: Business
Episode 81: Vaping upheaval, DNA test dynamics, & the future of genome editing
Published: Sept. 26, 2019, 8:45 p.m.Duration: 26 minutes 1 second
Listed in: Business
Episode 80: Unicorn growth spurts, Amgen's future, & mice on Twitter
Published: Sept. 19, 2019, 9:26 p.m.Duration: 29 minutes 7 seconds
Listed in: Business
Episode 79: Pelosi's drug pricing plan, Moderna's mRNA drug factories, and a DIY disease cure
Published: Sept. 12, 2019, 6:39 p.m.Duration: 19 minutes 36 seconds
Listed in: Business
Episode 78: Pharma existentialism, mainstreaming cyborgs, & FDA palace intrigue
Published: Sept. 5, 2019, 8:10 p.m.Duration: 24 minutes 27 seconds
Listed in: Business
Episode 77: Purdue, J&J, and a week of big opioid crisis news
Published: Aug. 29, 2019, 8:03 p.m.Duration: 18 minutes 17 seconds
Listed in: Business
Episode 76: Sarepta keeps a secret, an online army mobilizes, & China embraces biotech
Published: Aug. 22, 2019, 9:02 p.m.Duration: 23 minutes 20 seconds
Listed in: Business
Episode 75: The serious side of spit kits, how BiTEs leave a mark, & Sarepta's sluggish study
Published: Aug. 15, 2019, 8:23 p.m.Duration: 29 minutes 38 seconds
Listed in: Business
Episode 74: Novartis and the no good, very bad week
Published: Aug. 8, 2019, 8:35 p.m.Duration: 19 minutes 33 seconds
Listed in: Business
Episode 73: Canadian pills, corporate jets, & racists with spit kits
Published: Aug. 1, 2019, 8:36 p.m.Duration: 23 minutes 51 seconds
Listed in: Business
Episode 72: Vertex's regime change, the return of Ebola, & the rise of digital health
Published: July 25, 2019, 8:36 p.m.Duration: 26 minutes 33 seconds
Listed in: Business
Episode 71: Elon Musk's monkey cyborg, Gilead's shifting future, & an app for anxiety
Published: July 18, 2019, 7:16 p.m.Duration: 25 minutes 37 seconds
Listed in: Business
Episode 70: A whirlwind week in Washington, Sean Parker's mansion, & remembering a voice in biotech
Published: July 11, 2019, 8:32 p.m.Duration: 29 minutes 52 seconds
Listed in: Business
Episode 69: The future of AbbVieGan, the dogma of amyloid, & some questionable biotech marketing
Published: June 27, 2019, 8:50 p.m.Duration: 25 minutes 31 seconds
Listed in: Business
Episode 68: A controversial desire drug, courtroom genealogy, & the quest for longer life
Published: June 20, 2019, 8:29 p.m.Duration: 26 minutes 49 seconds
Listed in: Business
Episode 67: Biohacking meets bureaucracy, and the latest twist in CRISPR world
Published: June 13, 2019, 9:02 p.m.Duration: 25 minutes 3 seconds
Listed in: Business
Episode 66: The future of cancer treatment, blockbusters interrupted, & an infamous biotech party
Published: June 6, 2019, 8:34 p.m.Duration: 26 minutes 52 seconds
Listed in: Business
Episode 65: A special episode from the halls of the ASCO meeting
Published: June 4, 2019, 8:34 p.m.Duration: 29 minutes 25 seconds
Listed in: Business
Episode 64: Feuding professors, failing businesses, and journalism 101
Published: May 30, 2019, 8 p.m.Duration: 23 minutes 59 seconds
Listed in: Business
Episode 63: Your ASCO preview, genetic whiplash, and a journalist's experience with cancer
Published: May 23, 2019, 9:20 p.m.Duration: 31 minutes 33 seconds
Listed in: Business
Episode 62: Drug pricing partisanship, tech's march into health care, and Tinder for clinical trials
Published: May 16, 2019, 8:35 p.m.Duration: 23 minutes 24 seconds
Listed in: Business
Episode 61: Pharma felonies, cardiac CRISPR, and a strange day at the FDA
Published: May 9, 2019, 8:12 p.m.Duration: 25 minutes 3 seconds
Listed in: Business
Episode 60: Boardroom drama, whiskey-fueled science, & millionaires on mushrooms
Published: May 2, 2019, 9:14 p.m.Duration: 22 minutes 20 seconds
Listed in: Business
Episode 59: When scientists get mad online, for-profit cancer care, & the perils of naming a startup
Published: April 25, 2019, 8:24 p.m.Duration: 22 minutes 17 seconds
Listed in: Business
Episode 58: Democratizing CRISPR, drugging the undruggable, and reading pharma's fine print
Published: April 18, 2019, 8:05 p.m.Duration: 21 minutes 34 seconds
Listed in: Business
Episode 57: Trumps drug pricing foot soldier, Gileads uncertain future, & transpacific angst
Published: April 11, 2019, 9:08 p.m.Duration: 25 minutes 21 seconds
Listed in: Business
Episode 56: Cheaper insulin, the next Juul, and diagnosing disease with sound
Published: April 4, 2019, 9:57 p.m.Duration: 28 minutes 51 seconds
Listed in: Business
Episode 55: The fate of Bristol-Myers-Celgene, the tragedy of SIDS, and health tech's challenges
Published: March 28, 2019, 8:29 p.m.Duration: 26 minutes 32 seconds
Listed in: Business
Episode 54: Another big Alzheimers failure, postpartum progress, and Long Island shores
Published: March 21, 2019, 9:20 p.m.Duration: 31 minutes 4 seconds
Listed in: Business
Episode 53: How startups stop, the new FDA boss, and Theranos on the big screen
Published: March 14, 2019, 9:11 p.m.Duration: 31 minutes 45 seconds
Listed in: Business
Episode 52: Every conceivable angle of Scott Gottlieb's FDA resignation
Published: March 7, 2019, 11:30 p.m.Duration: 28 minutes 28 seconds
Listed in: Business
Episode 51: CEOs at the Senate, merger mania, and sleuthing startups
Published: Feb. 28, 2019, 11:21 p.m.Duration: 26 minutes 26 seconds
Listed in: Business
Episode 50: A big scoop on opioid marketing
Published: Feb. 22, 2019, 6:29 p.m.Duration: 13 minutes 10 seconds
Listed in: Business
Episode 49: Painkiller racketeering, the limits of genetic tests, and pharma's day on the Hill
Published: Feb. 21, 2019, 10:14 p.m.Duration: 23 minutes 54 seconds
Listed in: Business
Episode 48: The AI hype machine, ketamine's future, and the rocky path ahead for NASH
Published: Feb. 14, 2019, 10:40 p.m.Duration: 23 minutes 46 seconds
Listed in: Business
Episode 47: A bad day for bold biotech, campaign 2020, and where do drugs come from?
Published: Feb. 7, 2019, 11:31 p.m.Duration: 26 minutes 27 seconds
Listed in: Business
Episode 46: Another Alzheimer's setback, crypto for biotech, and a blessing of unicorns
Published: Jan. 31, 2019, 9:56 p.m.Duration: 24 minutes 34 seconds
Listed in: Business
Episode 45: CRISPR upheaval, Celgene's chutzpah, and canine genomics
Published: Jan. 24, 2019, 10:37 p.m.Duration: 24 minutes 54 seconds
Listed in: Business
Episode 44: FDA furloughs, '80s pop radio, and video game therapeutics
Published: Jan. 17, 2019, 10:05 p.m.Duration: 23 minutes 55 seconds
Listed in: Business
Episode 43: A people's history of J.P. Morgan
Published: Jan. 10, 2019, 11:30 p.m.Duration: 14 minutes 45 seconds
Listed in: Business
Episode 42: Parsing Bristol-Myers-Celgene, grousing about JPM, and how to not be boring
Published: Jan. 3, 2019, 11:05 p.m.Duration: 22 minutes 5 seconds
Listed in: Business
Episode 41: Watson's latest stumble, a glimpse into the crystal ball, and revisiting Sarepta
Published: Dec. 20, 2018, 10:08 p.m.Duration: 26 minutes 38 seconds
Listed in: Business
Episode 40: Gileads new boss, the year that was, and the thing about DNA tests
Published: Dec. 13, 2018, 10:05 p.m.Duration: 23 minutes 16 seconds
Listed in: Business
Episode 39: Using the word 'cure,' an FDA loophole, & making biotech history
Published: Dec. 6, 2018, 9:05 p.m.Duration: 22 minutes 45 seconds
Listed in: Business
Episode 38: Your guide to the #CRISPRbabies controversy
Published: Nov. 29, 2018, 9:26 p.m.Duration: 23 minutes 56 seconds
Listed in: Business
Episode 37: The biggest-ever IPO, drug prices rising in tandem, and burner Twitter accounts
Published: Nov. 15, 2018, 10:15 p.m.Duration: 26 minutes 17 seconds
Listed in: Business
Episode 36: What the midterms mean, a golden age on hold, and the $4 million drug
Published: Nov. 8, 2018, 10:31 p.m.Duration: 22 minutes 46 seconds
Listed in: Business
Episode 35: Biotech's October slump, the precise cost of precision, and breaking postpartum silence
Published: Nov. 1, 2018, 10:05 p.m.Duration: 26 minutes 12 seconds
Listed in: Business
Episode 34: Pharma at the ballot box, the latest Alzheimer's argument, and a rare disease dilemma
Published: Oct. 25, 2018, 9:14 p.m.Duration: 21 minutes 35 seconds
Listed in: Business
Episode 33: Drug prices on TV, immortal blockbusters, and genetic privacy
Published: Oct. 18, 2018, 9:07 p.m.Duration: 24 minutes 33 seconds
Listed in: Business
Episode 32: Fake friends at the FDA, cancer counter-narratives, and biotech's bear turn
Published: Oct. 11, 2018, 8:13 p.m.Duration: 22 minutes 47 seconds
Listed in: Business
Episode 31: Nobel snubs, millenial founders, and a new kind of lightning round
Published: Oct. 4, 2018, 5:50 p.m.Duration: 23 minutes 42 seconds
Listed in: Business
Episode 30: A fish oil epiphany, VC monopolies and ketamine clinics
Published: Sept. 27, 2018, 8:38 p.m.Duration: 25 minutes 13 seconds
Listed in: Business
Episode 29: A Hong Kong heat-check, a $20 million wrist slap, and pharma's (other) diversity problem
Published: Sept. 20, 2018, 8:32 p.m.Duration: 24 minutes 38 seconds
Listed in: Business
Episode 28: Founders' funds, doctors' disclosures, and the subtle art of beeping
Published: Sept. 13, 2018, 9:46 p.m.Duration: 22 minutes 57 seconds
Listed in: Business
Episode 27: Live from Boston!
Published: Sept. 6, 2018, 9:31 p.m.Duration: 26 minutes 8 seconds
Listed in: Business
Episode 26: FDA shows its teeth, biotech fish oil might be pointless, & treating McCain's cancer
Published: Aug. 30, 2018, 7:10 p.m.Duration: 17 minutes 57 seconds
Listed in: Business
Episode 25: A genome-editing first, Trump on Wall Street, and biotech red flags
Published: Aug. 23, 2018, 7:07 p.m.Duration: 21 minutes 48 seconds
Listed in: Business
Episode 24: A lesson in startup jargon, pharma's bare Alzheimer's cupboard, and the cost of CAR-T
Published: Aug. 16, 2018, 8:27 p.m.Duration: 23 minutes 52 seconds
Listed in: Business
Episode 23: Congressional insider trading, PETA and fake meat, & doctors vs. fund managers
Published: Aug. 9, 2018, 8:03 p.m.Duration: 21 minutes 9 seconds
Listed in: Business
Episode 22: Biotech's battle for talent, Sanofi's second act, and climbing Mt. Everest
Published: Aug. 2, 2018, 8:55 p.m.Duration: 23 minutes 2 seconds
Listed in: Business
Episode 21 - A debatable Alzheimer's breakthrough, Gilead's golden age, and "robust" data
Published: July 26, 2018, 8:19 p.m.Duration: 24 minutes 58 seconds
Listed in: Business
Episode 20 - CRISPR freakouts, drug prices meet elections, and a busy earnings season
Published: July 19, 2018, 10:56 p.m.Duration: 25 minutes 30 seconds
Listed in: Business
Episode 19: Trump's telephonic prowess, Biogen's mysterious future, & the rise of 'hypelines'
Published: July 12, 2018, 9:57 p.m.Duration: 24 minutes 46 seconds
Listed in: Business
Episode 18: Biotech's six-month review, how to become a day trader and soul-searching analysts
Published: July 5, 2018, 9:14 p.m.Duration: 19 minutes 49 seconds
Listed in: Business
Episode 17: A friendly FDA, biosimilar awkwardness and how to sell drugs in China
Published: June 28, 2018, 10:03 p.m.Duration: 23 minutes 11 seconds
Listed in: Business
Episode 16: Sarepta's big week, Theranos' legal woes and parsing AI hype
Published: June 21, 2018, 10:10 p.m.Duration: 25 minutes 45 seconds
Listed in: Business
Episode 15: Problematic parties, Nitpicking NASH, and an opioid documentary from STAT
Published: June 14, 2018, 10:22 p.m.Duration: 23 minutes 45 seconds
Listed in: Business
Episode 14: Twitter vitriol, biotech jargon, and the plight of the CEO
Published: June 7, 2018, 10:24 p.m.Duration: 26 minutes 56 seconds
Listed in: Business
Episode 13: Spending millions on fatty liver disease. Overhyped cancer drugs. Who goes to BIO?
Published: May 31, 2018, 9:38 p.m.Duration: 22 minutes 31 seconds
Listed in: Business
Episode 12: Ebola should worry you, again; 23andMe's World Cup whoops; Don't drink sunscreen
Published: May 24, 2018, 9:40 p.m.Duration: 27 minutes 48 seconds
Listed in: Business
Episode 11: Inside the Theranos collapse, Valeant's latest legal lumps, and a few biotech hot takes
Published: May 17, 2018, 10:02 p.m.Duration: 22 minutes 45 seconds
Listed in: Business
Episode #10: Cohen, Trump, Novartis, oh my; Spark + Amish; Genetic testing at your doc's office?
Published: May 10, 2018, 9:58 p.m.Duration: 22 minutes 28 seconds
Listed in: Business
Episode #9 - Bill Gates on deadly flu, Chinese biotech bubbles, Golden State killer genetics
Published: May 3, 2018, 9:59 p.m.Duration: 27 minutes 37 seconds
Listed in: Business
Episode #8 - Megamergers, migraines, and biotech's Four Horsemen
Published: April 26, 2018, 9:11 p.m.Duration: 25 minutes 4 seconds
Listed in: Business
Episode #7 - Coke and Pepsi of lung cancer, a debatable drug price, and a cure for capitalism
Published: April 19, 2018, 10:45 p.m.Duration: 21 minutes 55 seconds
Listed in: Business
Episode #6 - Biotech buyouts, CEO breakups, and The Rock does CRISPR
Published: April 12, 2018, 9:17 p.m.Duration: 23 minutes 33 seconds
Listed in: Business
Episode #5 - The FDA's cold shoulder, the latest CAR-T contender, and BuzzFeed's scoop on Grindr
Published: April 5, 2018, 9:10 p.m.Duration: 22 minutes 32 seconds
Listed in: Business
Episode #4 - Mr. Drug CEO doesn't go to DC, billionaires fighting drug prices, a biotech report card
Published: March 29, 2018, 9:06 p.m.Duration: 23 minutes 36 seconds
Listed in: Business
Episode #3 - A gene therapy story, breaking down Incytes future, and was Gottlieb wrong to try?
Published: March 22, 2018, 9:03 p.m.Duration: 24 minutes 46 seconds
Listed in: Business
Episode #2 - Theranoss fate, biotechs awkward SXSW, and a word on cow loogies
Published: March 15, 2018, 9:51 p.m.Duration: 21 minutes 41 seconds
Listed in: Business
Episode #1 - Shkreli's sentence, biotech froth, and a blood party
Published: March 8, 2018, 11:06 p.m.Duration: 18 minutes 23 seconds
Listed in: Business
Coming soon: "The Readout LOUD"
Published: March 2, 2018, 6:03 p.m.Duration: 1 minute 15 seconds
Listed in: Business